Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 3/20 | 0.45 |
| ▸ | MDM4 | O15151 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | GRB2 | P62993 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29858305 | 0.93 | CASP3 (0.46) | CASP3MDM4TP53PTPN1GRB2 | |
| SCHEMBL30945914 | 0.87 | MDM4 (0.48) | CASP3MDM4TP53PTPN1GRB2 | |
| SCHEMBL29051485 | 0.86 | CASP3 (0.49) | CASP3MDM4TP53PIN1 | |
| SCHEMBL31355420 | 0.86 | CASP3 (0.49) | CASP3MDM4TP53PIN1 | |
| SCHEMBL29052325 | 0.83 | CASP3 (0.45) | CASP3MDM4TP53PIN1 | |
| SCHEMBL15702063 | 0.82 | CASP3 (0.51) | CASP3MDM4TP53PTPN1MDM2 | |
| SCHEMBL31453529 | 0.82 | CASP3 (0.45) | CASP3MDM4TP53PIN1 | |
| SCHEMBL30892068 | 0.82 | PTPN1 (0.49) | CASP3MDM4TP53PTPN1 | |
| SCHEMBL30261589 | 0.82 | CTSB (0.49) | CASP3PTPN1PIN1 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL120560 | 0.81 | MDM4 (0.58) | CASP3MDM4TP53PTPN1MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025092769-A1 | PREPARATION METHOD FOR DUAL GIP AND GLP-1 RECEPTOR AGONIST | 博瑞生物医药（苏州）股份有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-119930756-A | Preparation method of dual receptor agonist of GIP and GLP-1 | 博瑞生物医药（苏州）股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-121914206-A | Preparation method of short peptide Fmoc-Ile-Aib-Leu (S) -Asp (tBu) -OH and intermediate thereof | 扬州奥锐特药业有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-121914206-A | Preparation method of short peptide Fmoc-Ile-Aib-Leu (S) -Asp (tBu) -OH and intermediate thereof | 扬州奥锐特药业有限公司 | 2026-04-24 | — | — | CN | disclosed |
| WO-2025092769-A1 | PREPARATION METHOD FOR DUAL GIP AND GLP-1 RECEPTOR AGONIST | 博瑞生物医药（苏州）股份有限公司 | 2025-05-08 | — | — | WO | disclosed |
| CN-119930756-A | Preparation method of dual receptor agonist of GIP and GLP-1 | 博瑞生物医药（苏州）股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119874492-A | Novel method for synthesizing teicoplanin fragment | 九洲药业(杭州)有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-116178523-A | Synthetic method of Tirzepatide | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-115160429-A | Preparation method of Tirzepatide | 深圳市健元医药科技有限公司 | 2022-10-11 | — | — | CN | disclosed |